Cystatin C and subclinical brain infarction

Journal of the American Society of Nephrology

Volumn 16, Issue 12, 2005, Pages 3721-3727

  Seliger, Stephen L ^a   Longstreth, W T ^b   Katz, Ronit ^b   Manolio, Teri ^c   Fried, Linda F ^d   Shlipak, Michael ^e   Stehman Breen, Catherine O ^f   Newman, Anne ^g   Sarnak, Mark ^h   Gillen, Daniel L ⁱ   Bleyer, Anthony ^j   Siscovick, David S ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d VA Healthcare VISN 4   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f AMGEN INC   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^h TUFTS MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CHICAGO   (United States)

^j WAKE FOREST SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CREATININE; CYSTATIN C; BIOLOGICAL MARKER; CYSTATIN;

AGED; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GERIATRIC PATIENT; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RADIODIAGNOSIS; AGE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DISEASE COURSE; GERIATRIC ASSESSMENT; HOSPITALIZATION; INCIDENCE; METABOLISM; METHODOLOGY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION AND FORECASTING; PROGNOSIS; RISK; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SURVIVAL; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN INFARCTION; CONFIDENCE INTERVALS; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATINS; DISEASE PROGRESSION; FEMALE; GERIATRIC ASSESSMENT; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE IMAGING; MALE; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 33645896734     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005010006     Document Type: Article

References (31)

1. Price TR, Manolio TA, Kronmal RA, Kittner SJ, Yue NC, Robbins J, Anton-Culver H, O'Leary DH: Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 28: 1158-1164, 1997
2. Bernick C, Kuller L, Dulberg C, Longstreth WT Jr, Manolio T, Beauchamp N, Price T; Cardiovascular Health Study Collaborative Reseach Group: Silent MRI infarcts and the risk of future stroke: The Cardiovascular Health Study. Neurology 57: 1222-1229, 2001
3. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S: Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 28: 1932-1939, 1997
4. Vermeer SE, den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM; Rotterdam Scan Study: Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 34: 392-396, 2003
5. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM; Rotterdam Scan Study: Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam Scan Study. Stroke 34: 1126-1129, 2003
6. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348: 1215-1222, 2003
7. Longstreth WT Jr, Dulberg C, Manolio TA, Lewis MR, Beauchamp NJ Jr, O'Leary D, Carr J, Furberg CD: Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: The Cardiovascular Health Study. Stroke 33: 2376-2382, 2002
8. Seliger SL, Gillen DL, Longstreth WT Jr, Kestenbaum B, Stehman-Breen CO: Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 64: 603-609, 2003
9. Wannamethee SG, Shaper AG, Perry IJ: Serum creatinine concentration and risk of cardiovascular disease: A possible marker for increased risk of stroke. Stroke 28: 557-563, 1997
10. Shlipak MG, Simon JA, Grady D, Lin F, Wenger NK, Furberg CD; Heart and Estrogen/progestin Replacement Study (HERS) Investigators: Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol 38: 705-711, 2001
11. Manolio TA, Kronmal RA, Burke GL, O'Leary DH, Price TR: Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study. Stroke 27: 1479-1486, 1996
12. Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB: Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41: 1364-1372, 2003
13. Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, Tabata T, Inoue T, Morii H: High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48: 820-826, 1995
14. Pascazio L, Bianco F, Giorgini A, Galli G, Curri G, Panzetta G: Echo color Doppler imaging of carotid vessels in hemodialysis patients: Evidence of high levels of atherosclerotic lesions. Am J Kidney Dis 28: 713-720, 1996
15. Savage T, Clarke AL, Giles M, Tomson CR, Raine AE: Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant 13: 2004-2012, 1998
16. Zoungas S, Ristevski S, Lightfoot P, Liang YL, Branley P, Shiel LM, Kerr P, Atkins R, McNeil JJ, McGrath BP: Carotid artery intima-medial thickness is increased in chronic renal failure. Clin Exp Pharmacol Physiol 27: 639-641, 2000
17. Kennedy R, Case C, Fathi R, Johnson D, Isbel N, Marwick TH: Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease? Am J Med 110: 198-204, 2001
18. Ishimura E, Shoji T, Emoto M, Motoyama K, Shinohara K, Matsumoto N, Taniwaki H, Inaba M, Nishizawa Y: Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus. Am J Kidney Dis 38: S186-S190, 2001
19. Leoncini G, Viazzi F, Parodi D, Vettoretti S, Ratto E, Ravera M, Tomolillo C, Del Sette M, Bezante GP, Deferrari G, Pontremoli R: Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension 42: 14-18, 2003
20. Kobayashi S, Ikeda T, Moriya H, Ohtake T, Kumagai H: Asymptomatic cerebral lacunae in patients with chronic kidney disease. Am J Kidney Dis 44: 35-41, 2004
21. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR: Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: The Cardiovascular Health Study. Arch Neurol 55: 1217-1225, 1998
22. Dharnidharka VR, Kwon C, Stevens G: Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 40: 221-226, 2002
23. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65: 1416-1421, 2004
24. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, et al.: The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1: 263-276, 1991
25. Price TR, Psaty B, O'Leary D, Burke G, Gardin J: Assessment of cerebrovascular disease in the Cardiovascular Health Study. Ann Epidemiol 3: 504-507, 1993
26. Bryan RN, Manolio TA, Schertz LD, Jungreis C, Poirier VC, Elster AD, Kronmal RA: A method for using MR to evaluate the effects of cardiovascular disease on the brain: The Cardiovascular Health Study. AJNR Am J Neuroradiol 15: 1625-1633, 1994
27. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27: 1274-1282, 1996
28. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39[Suppl 1]: S17-S31, 2002
29. O'Leary DH, Polak JF, Wolfson SK Jr, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA: Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 22: 1155-1163, 1991
30. Lemeshow S, Hosmer DW Jr: A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115: 92-106, 1982
31. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352: 2049-2060, 2005